HUP9701057A3 - Substituted benzoylguanidine derivatives, process for producing - Google Patents

Substituted benzoylguanidine derivatives, process for producing

Info

Publication number
HUP9701057A3
HUP9701057A3 HU9701057A HUP9701057A HUP9701057A3 HU P9701057 A3 HUP9701057 A3 HU P9701057A3 HU 9701057 A HU9701057 A HU 9701057A HU P9701057 A HUP9701057 A HU P9701057A HU P9701057 A3 HUP9701057 A3 HU P9701057A3
Authority
HU
Hungary
Prior art keywords
producing
benzoylguanidine derivatives
substituted benzoylguanidine
substituted
derivatives
Prior art date
Application number
HU9701057A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HU9701057D0 publication Critical patent/HU9701057D0/hu
Publication of HUP9701057A2 publication Critical patent/HUP9701057A2/hu
Publication of HUP9701057A3 publication Critical patent/HUP9701057A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU9701057A 1996-06-18 1997-06-17 Substituted benzoylguanidine derivatives, process for producing HUP9701057A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19624178A DE19624178A1 (de) 1996-06-18 1996-06-18 Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (3)

Publication Number Publication Date
HU9701057D0 HU9701057D0 (en) 1997-08-28
HUP9701057A2 HUP9701057A2 (hu) 1998-12-28
HUP9701057A3 true HUP9701057A3 (en) 2000-08-28

Family

ID=7797197

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701057A HUP9701057A3 (en) 1996-06-18 1997-06-17 Substituted benzoylguanidine derivatives, process for producing

Country Status (31)

Country Link
US (1) US6001881A (hu)
EP (1) EP0814077B1 (hu)
JP (1) JP3977897B2 (hu)
KR (1) KR100498799B1 (hu)
CN (1) CN1064676C (hu)
AR (1) AR012536A1 (hu)
AT (1) ATE191469T1 (hu)
AU (1) AU711734B2 (hu)
BR (1) BR9703617A (hu)
CA (1) CA2207886A1 (hu)
CZ (1) CZ291848B6 (hu)
DE (2) DE19624178A1 (hu)
DK (1) DK0814077T3 (hu)
ES (1) ES2146049T3 (hu)
GR (1) GR3033299T3 (hu)
HR (1) HRP970332B1 (hu)
HU (1) HUP9701057A3 (hu)
ID (1) ID17321A (hu)
IL (1) IL121085A0 (hu)
MX (1) MX9704486A (hu)
MY (1) MY117304A (hu)
NO (1) NO307928B1 (hu)
NZ (1) NZ328100A (hu)
PL (1) PL185756B1 (hu)
PT (1) PT814077E (hu)
RU (1) RU2193025C2 (hu)
SI (1) SI0814077T1 (hu)
SK (1) SK282351B6 (hu)
TR (1) TR199700508A2 (hu)
TW (1) TW374759B (hu)
ZA (1) ZA975312B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19608161A1 (de) * 1996-03-04 1997-09-11 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19713427A1 (de) * 1997-04-01 1998-10-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10001879A1 (de) * 2000-01-19 2001-07-19 Aventis Pharma Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6641811B1 (en) * 2000-02-10 2003-11-04 Cornell Research Foundation, Inc. Use of angiotensin II inhibitors to prevent malignancies associated with immunosuppression
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4430213A1 (de) * 1994-08-28 1996-02-29 Merck Patent Gmbh Arylbenzoylguanidine
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19608162A1 (de) * 1996-03-04 1997-09-11 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
CA2207886A1 (en) 1997-12-18
ES2146049T3 (es) 2000-07-16
EP0814077A1 (de) 1997-12-29
KR980002020A (ko) 1998-03-30
PL320326A1 (en) 1997-12-22
MX9704486A (es) 1997-12-31
ZA975312B (en) 1998-01-05
ATE191469T1 (de) 2000-04-15
EP0814077B1 (de) 2000-04-05
KR100498799B1 (ko) 2005-12-16
CN1064676C (zh) 2001-04-18
GR3033299T3 (en) 2000-09-29
NO307928B1 (no) 2000-06-19
MY117304A (en) 2004-06-30
JPH1067733A (ja) 1998-03-10
RU2193025C2 (ru) 2002-11-20
HUP9701057A2 (hu) 1998-12-28
CZ291848B6 (cs) 2003-06-18
PT814077E (pt) 2000-07-31
JP3977897B2 (ja) 2007-09-19
SI0814077T1 (en) 2000-08-31
SK76697A3 (en) 1998-01-14
NZ328100A (en) 1998-09-24
DE59701388D1 (de) 2000-05-11
TR199700508A2 (xx) 1998-01-21
HRP970332A2 (en) 1998-04-30
PL185756B1 (pl) 2003-07-31
SK282351B6 (sk) 2002-01-07
CN1169987A (zh) 1998-01-14
IL121085A0 (en) 1997-11-20
CZ188797A3 (cs) 1998-05-13
AU2494297A (en) 1998-01-08
TW374759B (en) 1999-11-21
HU9701057D0 (en) 1997-08-28
NO972793L (no) 1997-12-19
US6001881A (en) 1999-12-14
NO972793D0 (no) 1997-06-17
AR012536A1 (es) 2000-11-08
ID17321A (id) 1997-12-18
BR9703617A (pt) 1998-09-29
DE19624178A1 (de) 1998-01-08
AU711734B2 (en) 1999-10-21
DK0814077T3 (da) 2000-08-14
HRP970332B1 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
MXPA98006731A (es) Procedimiento para producir n-acetil-d-glucosamina.
HUP9603179A3 (en) Process for producing benzyl-ethers
HUP9800615A3 (en) Process for producing bis-hydroxy-methyl derivatives
EP0702008A3 (en) Process for the preparation of 1,2-benzisothiazol-3-ones
GB2311522B (en) Process for producing perfluorocarbon
HUP9700140A3 (en) Process for producing 0-demethyl-tramadol-enantiomeres
HUP9700380A2 (en) Process for producing 4-oxoimidazolinium-salts
HUT64030A (en) Process for producing dialkyl-2,3-pyridinedicarboxylate derivatives
HU9700212D0 (en) Process for producing alkyl-chlorides
HUP0003203A3 (en) Process for producing bisindolymalimides
HUP9800540A3 (en) Process for producing 2,6-pyridin-dicarbonacid ester derivatives
IL117406A0 (en) Novel process for preparing 2,3-dihydro-benzofuranol derivatives
AU3255997A (en) Process for preparing 1,3-alkanediols
AU5708498A (en) Process for producing 1,1,1,2,3,3,3-heptafluoropropane
HUP9701057A3 (en) Substituted benzoylguanidine derivatives, process for producing
HUP9701013A3 (en) Process for producing cephem-and isooxacephem derivatives
HUP9802054A3 (en) Process for producing 4,4,5,5,5-pentafluor-1-pentanol
EP0794002A3 (en) Process for producing mixed-cation zeolites
HUP9802105A3 (en) Process for producing 2,3,4,5-tetrafluorbenzene derivatives
EP0874059A4 (en) PROCESSES FOR THE PRODUCTION OF INDAN DERIVATIVES
AU3026697A (en) Process for preparing 4,6-diamino-resorcinol-dihydrochloride
HUP9802646A3 (en) Process for producing formylimidazol derivatives
EP0751111A3 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
AU2681597A (en) Processes for producing 1,6-hexanediols
HU9700026D0 (en) Process for producing 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thion derivatives